Converting from Fentanyl 75 µg/hour Patch to Methadone
For a patient on a 75 µg/hour fentanyl patch, initiate oral methadone at 15-22.5 mg daily divided into 3-4 doses (approximately 5 mg every 6-8 hours), starting 8-12 hours after patch removal, with careful titration every 5-7 days based on clinical response.
Conversion Calculation
The conversion from transdermal fentanyl to methadone requires a two-step process:
Step 1: Convert fentanyl to oral morphine equivalent
- A 75 µg/hour fentanyl patch equals approximately 180 mg/day oral morphine 1
Step 2: Convert morphine equivalent to methadone
- For morphine doses of 91-300 mg/day, use a conversion ratio of 5:1 to 10:1 (morphine:methadone) 1
- 180 mg oral morphine ÷ 8-12 = 15-22.5 mg methadone daily
- Reduce this calculated dose by 25-50% to account for incomplete cross-tolerance 1
- This yields a starting range of 7.5-17 mg methadone daily, though most clinicians would start at 15 mg daily for this dose level
Initiation Protocol
Timing of Methadone Start
- Remove the fentanyl patch
- Wait 8-12 hours before starting methadone 2
- This accounts for the continued absorption from the subcutaneous fentanyl depot (serum levels fall 50% in 20-27 hours after patch removal) 3
Initial Dosing Schedule
Divide the total daily methadone dose into 3-4 doses:
- For 15 mg daily: Give 5 mg every 8 hours (3 divided doses) 1
- Alternative: 3.75 mg every 6 hours (4 divided doses)
Breakthrough Pain Management
- Provide short-acting opioid rescue doses during the first 24-72 hours 1
- Use immediate-release morphine 5-10 mg or equivalent every 2-4 hours as needed
- Monitor total rescue medication use to guide subsequent dose adjustments
Titration Schedule
Critical timing consideration: Methadone has a long and variable half-life (15-120 hours), with steady-state potentially taking 4-5 days to 2 weeks 4, 1.
Dose Adjustment Protocol
- First adjustment: Day 5-7 after initiation 1
- Increase by 5-10 mg per dose based on pain control and rescue medication use 1
- Subsequent adjustments: Every 5-7 days minimum 1
- Never adjust more frequently than every 5 days due to accumulation risk
Monitoring Requirements
- Baseline ECG before initiation (methadone prolongs QTc) 1
- Follow-up ECG if dose exceeds 100 mg/day or patient has cardiac disease 1
- Monitor for oversedation, respiratory depression, and confusion
- Assess pain scores and functional improvement at each visit
Critical Safety Considerations
The Methadone Conversion Paradox
The conversion ratio varies with baseline opioid dose—higher morphine doses require MORE conservative methadone ratios 1. For 180 mg morphine equivalent, the 8:1 to 10:1 ratio is appropriate, but this becomes 12:1 or higher for doses >300 mg morphine equivalent.
Common Pitfalls to Avoid
- Never use these ratios in reverse (converting FROM methadone to other opioids requires different calculations) 1
- Do not titrate based on early response—methadone's delayed peak effect means Day 1-2 pain control does not reflect steady-state efficacy 4, 1
- Account for drug interactions—methadone is metabolized by CYP3A4; interactions with antiretrovirals, antifungals, and other medications can significantly alter levels 1
- Recognize incomplete cross-tolerance—always reduce the calculated equianalgesic dose by 25-50% 1
Consultation Recommendation
The NCCN guidelines explicitly state: "PRACTITIONERS ARE ADVISED TO CONSULT WITH A PAIN OR PALLIATIVE CARE SPECIALIST IF THEY ARE UNFAMILIAR WITH METHADONE PRESCRIBING" 4. Given methadone's complex pharmacokinetics and potential for serious adverse events, consultation is strongly recommended for providers without extensive methadone experience.
Alternative Rapid Switching Approach
Recent research supports a rapid switching protocol using a fixed 1:20 ratio (fentanyl µg/hour : methadone mg/day) 5:
- 75 µg/hour fentanyl = 15 mg methadone daily (75 ÷ 5 = 15)
- This approach showed significant pain reduction within 24 hours
- Requires close monitoring and liberal rescue medication availability
- May be appropriate for inpatient settings with close supervision
However, this rapid approach lacks the conservative dose reduction recommended by major guidelines and should only be used with appropriate monitoring capabilities 2, 5.